Literature DB >> 21908373

Disseminated sclerosing peritoneal mesothelioma in a dog.

Sanjeev Gumber1, Natalie Fowlkes, Doo-Youn Cho.   

Abstract

A 7-year-old female German Shepherd Dog was presented with multiple petechiae and ecchymoses along the ventral abdomen, flank, and on the vaginal mucosa. The clinical diagnosis was severe hemoperitoneum and presumed disseminated intravascular coagulopathy. Postmortem examination revealed a 22 cm × 15 cm × 6 cm, firm, and convoluted peritoneal mass along with hemoperitoneum, and multifocal, ill-defined, 0.5-1.5 cm in diameter, white to tan nodules in the pulmonary parenchyma. Histologically, the peritoneal mass was composed of large anaplastic cells consistent with malignant mesothelioma interspersed in abundant fibrous connective tissue. Metastasis of the neoplastic cells occurred to the brain, adrenal glands, lymph nodes, and lungs. On immunohistochemical evaluation, neoplastic cells coexpressed cytokeratin and vimentin, and were negative for cluster of differentiation (CD)18. Electron microscopy revealed numerous surface microvilli around the entire circumference of the neoplastic cells, as well as tight junctions, and desmosome-like structures. Based on test findings, a disseminated sclerosing peritoneal mesothelioma was diagnosed.

Entities:  

Mesh:

Year:  2011        PMID: 21908373     DOI: 10.1177/1040638711416625

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Immunohistochemical characterization of mesothelioma in 6 large felids.

Authors:  Sarah E Coe; Michael M Garner; Matti Kiupel
Journal:  J Vet Diagn Invest       Date:  2021-05-13       Impact factor: 1.279

2.  Invasive pleural malignant mesothelioma with rib destruction and concurrent osteosarcoma in a dog.

Authors:  Morena Di Tommaso; Francesca Rocconi; Giuseppe Marruchella; Anna Rita D'Angelo; Stefano Masci; Domenico Santori; Carla Civitella; Alessia Luciani; Andrea Boari
Journal:  Acta Vet Scand       Date:  2015-12-02       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.